Influence of pubertal development on urinary oxidative stress biomarkers in adolescent girls in the New York LEGACY cohort. (2nd June 2020)

• Record Type: Journal Article
• Authors: Wu, Hui-Chen; Brennan, Laura A.; Goldberg, Mandy; Chung, Wendy K.; Wei, Ying; Santella, Regina M.; Terry, Mary Beth
• Is Part Of: Free radical research. Volume 54:Number 6(2020)
• Page Start: 431
• Page End: 441
• Publication Date: 2020-06-02
• Subjects: 8-oxodeoxyguanosine -- childhood and adolescent cohort -- F2-Isoprostanes -- puberty -- window of susceptibility; Free radicals (Chemistry) -- Periodicals; Antioxidants -- Periodicals; Vitamin C -- Periodicals; Vitamin E -- Periodicals; 541.224
• DOI: 10.1080/10715762.2020.1798001
• Languages: English
• ISSNs: 1071-5762

Abstract

Abstract: Puberty is a time of intense growth and differentiation of breast tissue and a window of susceptibility (WOS) for breast cancer. Although oxidative stress markers have been associated with breast cancer risk, it is unclear whether oxidative stress levels are different during the pubertal WOS, and if so, whether these differences are related to breast cancer susceptibility. We measured urinary biomarkers of whole body oxidative stress (urinary F2-Isoprostanes and 8-oxodeoxyguanosine (8-oxodG)) in 158 girls (ages 6–13 years), 71 with and 87 without a breast cancer family history (BCFH) from a cohort of adolescent girls from the New York site of the LEGACY cohort (Lessons in Epidemiology and Genetics in Adults Cancer from Youth). We compared levels of urinary oxidative stress biomarkers (F2-Isoprostanes and 8-oxodG) across the pubertal window, defined by Tanner Stage (TS) of breast development, both cross-sectionally and longitudinally within girls over an 18-month follow up period. Urinary oxidative stress biomarkers were unrelated to pubertal stages in cross-sectional analyses after considering adjustments for body mass index (BMI) and BCFH. In our longitudinal analysis, we found that urinary 8-oxodG levels, but not F2-Isoprostane levels, increased with age in BCFH + girls ( β = 6.12, 95% CI = 0.08–12.16) compared to BCFH-girls. Higher BMI was associated with higher level of F2-Isoprostane in both cross-sectional ( β = 0.02, 95% CI = 0.0004–0.05) and longitudinal analysis ( β = 0.02, 95% CI = 0.0002–0.05). These findings support that higher BMI increases oxidative stress biomarkers over the pubertal window and that there are changes in 8-oxodG oxidative stress biomarkers in girls with a BCFH compared to girls without a BCFH.